Related Experiment Video

Updated: Jul 16, 2025

Gold Nanorod-assisted Optical Stimulation of Neuronal Cells
09:31

Gold Nanorod-assisted Optical Stimulation of Neuronal Cells

Published on: April 27, 2015

9.0K

Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS

Steve Vucic1, Matthew C Kiernan2

  • 1Brain and Nerve Research Center, The University of Sydney, Sydney, Australia.

Expert Opinion on Investigational Drugs
|September 23, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ALSCNM-Au8MUNIXneurofilament

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.6K
Gold Nanoparticle Modified Carbon Fiber Microelectrodes for Enhanced Neurochemical Detection
07:34

Gold Nanoparticle Modified Carbon Fiber Microelectrodes for Enhanced Neurochemical Detection

Published on: May 13, 2019

9.6K

Related Experiment Videos

Last Updated: Jul 16, 2025

Gold Nanorod-assisted Optical Stimulation of Neuronal Cells
09:31

Gold Nanorod-assisted Optical Stimulation of Neuronal Cells

Published on: April 27, 2015

9.0K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.6K
Gold Nanoparticle Modified Carbon Fiber Microelectrodes for Enhanced Neurochemical Detection
07:34

Gold Nanoparticle Modified Carbon Fiber Microelectrodes for Enhanced Neurochemical Detection

Published on: May 13, 2019

9.6K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212

Articles linked to this work by shared authors, journal, and citation graph.

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis.

Brain communications·2023

Consensus for experimental design in electromyography (CEDE) project: Single motor unit matrix.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2022

Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials.

Expert review of neurotherapeutics·2022

Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

NeuroImage. Clinical·2022

Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial.

Trials·2022

Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis.

Muscle & nerve·2022

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

Expert opinion on investigational drugs·2026

Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density.

Expert opinion on investigational drugs·2026

Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products.

Expert opinion on investigational drugs·2026

Varespladib for snakebite envenoming: insights from therapeutic development and clinical trials.

Expert opinion on investigational drugs·2026

Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.

Expert opinion on investigational drugs·2026

Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.

Expert opinion on investigational drugs·2026

Photothermal-driven surface redox reconstruction of Mn3+-engineered α-MoO3/MnOx nanozyme for triple-negative breast cancer therapy.

Journal of materials chemistry. B·2026

Retinitis Pigmentosa and erythrocytic microcytosis related to hypomorphic variants in the TRNT1 gene.

Ophthalmic genetics·2026

Artificial Life in-materio: Creatures in a Nanomagnetic Metamaterial.

Artificial life·2026

Fluorescence resonance energy transfer-based aptasensor for rapid detection of aflatoxin M1 in milk.

Mikrochimica acta·2026

Comparative biomedical and photocatalytic efficacy of Malvastrum coromandelianum (L.) aqueous extract-assisted green synthesized zinc oxide and copper oxide nanoparticles.

International journal of phytoremediation·2026

An enzyme-responsive nanoplatform rewires host-microbe tryptophan metabolism for cancer immunotherapy.

Cell host & microbe·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us